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ABSTRACT: We developed a survey to look at psychiatrists’ attitudes toward psycho-
tropic prescribing guidelines, specifically the Texas Medication Algorithm Project
(TMAP) algorithms. The 22-page survey was distributed to 24 psychiatrists working
in 4 CMHC’s; 13 completed the survey. 90% agreed that guidelines should be general
and flexible. The majority also agreed that guidelines should define how to measure
response to a specific agent; fewer agreed guidelines should specify dosage, side effect
management, or augmentation strategies. Psychiatrists were familiar with TMAP; none
referred to it in their practice. In spite of this, psychiatrists’ medication preferences
were similar to those suggested by guidelines.
KEY WORDS: psychotropic medication guidelines; psychiatrists’ attitudes; community mental
health.
INTRODUCTION
In the last decade, practice guidelines have been developed for the
treatment of many chronic disorders, including severe and persistent
mental illnesses (e.g. Chiles et al., 2001). Guidelines are designed to
assist practitioners in making appropriate healthcare decisions in spe-
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cific clinical situations. However, meaningful change in practice has not
always resulted from guideline publication and dissemination (Mellman
et al., 2001; Torrey et al., 2001; Chilvers et al., 2002). This failure
may occur because clinicians are unaware of new guidelines, do not
familiarize themselves with guideline content, do not agree with treat-
ment recommendations, or do not work in settings with adequate logisti-
cal support for implementation (Milner and Valenstein, 2002). This
survey project was designed to look at the attitudes of psychiatrists
in a 4-county regional consortium of providers in Southeast Michigan
toward guidelines like the Texas Medication Algorithm Project (TMAP)
algorithms.
METHODS
A 22-page written survey comprised of yes/no, level of agreement, ranking, and open-
ended questions gathered information about demographics, practice site, and use of
guidelines. The survey was distributed to 24 psychiatrists working in four local Commu-
nity Mental Health Centers (CMHC). There was no phone or mail follow-up performed
to collect delinquent surveys. After commenting on established guidelines, clinicians
were given the opportunity to create their own algorithm of medications they would
choose for a particular illness, and explicate what factors are most important in medica-
tion choice. The survey also asked clinicians to choose an antipsychotic, mood stabilizer,
or antidepressant for patients with one other associated clinical condition, irrespective
of diagnosis. A treatment was considered preferred if 50% or more of clinicians chose
a particular medication for an associated condition.
RESULTS
Thirteen (54%) of the surveys were returned, and 70% of the respondents
were male. The mean age was 50 years of age, and the respondents had
been in practice an average of 20 years. All psychiatrists practiced in
at least one site other than the CMHC.
Sixty-nine percent of the psychiatrists were familiar with T-MAP,
but none referred to it in practice. 92% of the respondents strongly
agreed or agreed that guidelines should be general and flexible. There
was disagreement as to which factors should be weighed most heavily
in making prescribing decisions (Table 1). Clinicians rated medication
effectiveness as the most important factor in deciding which medication
to choose, but client history was also ranked highly. Cost was the least
important factor in medication choice.
Risperidone was the preferred antipsychotic in eight out of ten clinical
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TABLE 1
Psychiatrists’ Ranking of Factors Involved
in Medication Choice, on a Scale of 1 to 8 (1 = most
important to 8 = least important), Expressed
as Percent Choosing a Certain Rank
1 2 3 4 5 6 7 8
Effectiveness 57 31 15
Client history 46 15 15 15 8
Prescriber’s knowledge
of drug 15 15 23 39 8
Side effects 8 23 39 23 8
Previous non-compliance 8 15 23 31 23
Societal pressure to protect
citizens 8 8 15 69
Client preferences 31 8 31 8 15 8
Cost 8 8 8 8 54 15
conditions, and olanzapine was the choice for patients that were experi-
encing insomnia (Table 2). Parkinson disease was the only condition
for which there was not a preferred drug. Clinicians prescribing a mood
stabilizer preferred Depakote for nine of 15 conditions, lithium for two
conditions, and carbamazepine for one condition (Table 3). There was
no consensus for patients experiencing hypersomnia, agitation, or preg-
nancy. SSRIs were the preferred antidepressant treatment in 10 out of
11 conditions, while mirtazapine was the preferred drug for patients
with insomnia (Table 4).
DISCUSSION
In this survey, most clinicians were aware of the existence of treatment
guidelines, but do not consult treatment guidelines when making clinical
decisions. Therefore, lack of familiarity with guidelines is not the reason
that psychiatrists do not consult them. Instead, the negative attitudes
toward guidelines reflected in this study may be the reason why imple-
mentation is lagging. Clinicians do not want to follow rigid, prescriptive
guidelines; however, overly flexible guidelines would not be useful to
help guide clinical decision-making (Milner and Valenstein, 2002).
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As expected, clinicians consider several factors when choosing a psy-
chotropic medication. Effectiveness and client history are the two most
important variables when choosing a medication. Again, a guideline
should be able to account for these two factors, though research compar-
ing the efficacy of psychotropics is wanting. Right now, the clinician’s
definition of effectiveness reflects personal bias more than evidence-
based information. Interestingly, cost is the least important factor to
be considered when prescribing medication. This concern may increase
as budget cuts restrict the amount of funding available for prescription
drugs.
One of the criticisms of guidelines is that there are myriad clinical
variables for which guidelines cannot account (Milner and Valenstein,
2002). In spite of this antipathy, there was surprising agreement among
clinicians for certain clinical conditions (Tables 2–4). For example, clini-
cians chose risperidone, valproate, and SSRIs as the respective antipsy-
chotic, mood stabilizer, and antidepressant of choice in 60–91% of the
clinical scenarios (Tables 2–4). Further, only 4 of the 36 conditions did
not yield a majority choice (Tables 2–4). This consistency in medication
preference suggests that there is room for guidelines in usual care, at
least for the initial steps in a treatment guideline.
To conclude, the survey derived little support for guidelines that are
specific and prescriptive, although the psychiatrists were accepting
of guidelines that would be flexible, responsive, and more general. Fa-
miliarity alone is not sufficient to compel psychiatrists to implement
treatment guidelines, so consensus building and local adaptation of
guidelines are necessary prior to dissemination and implementation.
However, the surprising agreement in medication choice for different
clinical conditions suggests that there may be a foundation on which
to build this consensus. Finally, medication effectiveness is the most
important factor to psychiatrists when selecting a medication, so more
research comparing psychotropic medications will have a large and
beneficial impact on prescribing habits.
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